与同仁堂科技“零距离”沟通，投资者感受老字号新动能

Core Insights - The investor research event held on December 16 at Tong Ren Tang Technology Development Co., Ltd. showcased the company's modernization efforts and commitment to traditional craftsmanship in the context of its transformation [1] Group 1: Production and Technology - The production line at Tong Ren Tang employs automated and connected processes, ensuring a seamless workflow from pill production to packaging, highlighting the integration of traditional methods with modern technology [4] - The company aims to establish a modern intelligent manufacturing system for traditional Chinese medicine, ensuring that each pill maintains high quality and traceability [4] Group 2: Management Communication - During the event, the management team, led by General Manager Zhang Chunyou, engaged in detailed discussions with investors regarding the company's operational strategy, core product layout, capacity enhancement, and future growth potential [4] - The management emphasized the importance of transparent communication with investors to convey the company's cultural values, operational logic, and strategic planning [5] Group 3: Industry Context - The Chinese medicine industry is perceived to be entering a systematic development opportunity, supported by national health strategies and policies promoting traditional medicine [5] - Tong Ren Tang is positioned to leverage its brand, technology, and quality systems to deepen its engagement in the traditional medicine sector and explore new growth avenues [5]